Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Income from Continuing Operations came in at 15679000.0 in Q1 2026, up 42.39% year-on-year from 11011000.0 in Q1 2025, and down 12.38% on a QoQ basis from 17894000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Income from Continuing Operations data on file, last reported at 15679000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 42.39% year-over-year to 15679000.0 in Q1 2026; TTM through Mar 2026 was 64714000.0, a 11.58% increase from a year earlier, with the FY2025 full-year figure at 60046000.0, up 5.58% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 15679000.0, down from 17894000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for LMAT reached as high as 24021000.0 in Q4 2024 and fell as low as 3515000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 10713235.29 across 5 years, with a median of 9887000.0 in 2024.
- Across the five-year window, Income from Continuing Operations plunged 57.65% in 2022 and jumped 183.77% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 4411000.0 in 2022, then jumped by 91.91% to 8465000.0 in 2023, then soared by 183.77% to 24021000.0 in 2024, then retreated by 25.51% to 17894000.0 in 2025, then dropped by 12.38% to 15679000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 15679000.0 in Q1 2026, 17894000.0 in Q4 2025, and 17362000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.68 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 17.36 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | 24.02 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 11.83 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 8.10 Mn |
| Mar 31, 2023 | 6.04 Mn |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 6.04 Mn |
| Dec 31, 2021 | 6.04 Mn |
| Sep 30, 2021 | 6.50 Mn |
| Jun 30, 2021 | 8.30 Mn |